Long-Term Impact of Saroglitazar on Advanced Hepatic Fibrosis and Metabolic Dysfunction in MASLD patients: A Two-Year Case Series
Naresh Dang & Meenakshi Jain · Asian Journal of Case Reports in Medicine and Health · 2025
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in individuals with type 2 diabetes mellitus (T2DM). However, it remains an often overlooked hepatic comorbidity in this population. This case series contributes to the literature by...
Open access
Research Article
10.9734/ajcrmh/2025/v8i1252